The use of PET-MRI in the follow-up after radiofrequency- and microwave ablation of colorectal liver metastases

详细信息    查看全文

• 作者：Karin Nielsen (1)
  Hester J Scheffer (2)
  Indra C Pieters (2)
  Aukje AJM van Tilborg (2)
  Jan-Hein TM van Waesberghe (2)
  Daniela E Oprea-Lager (2)
  Martijn R Meijerink (2)
  Geert Kazemier (1)
  Otto S Hoekstra (2)
  Hermien WH Schreurs (3)
  Colin Sietses (4)
  Sybren Meijer (1)
  Emile FI Comans (2)
  Petrousjka MP van den Tol (1)
  
  1. Department of Surgery ; VU University Medical Center ; De Boelelaan 1117 ; 1081聽HV ; Amsterdam ; The Netherlands
  2. Radiology & Nuclear Medicine ; VU University Medical Center ; De Boelelaan 1117 ; 1081聽HV ; Amsterdam ; The Netherlands
  3. Department of Surgery ; Medical Center Alkmaar ; Postbus 501 ; 1800聽AM ; Alkmaar ; The Netherlands
  4. Department of Surgery ; Gelderse Vallei ; Willy Brandtlaan 10 ; 6716 RP ; Ede ; The Netherlands
  
• 关键词：Radiofrequency ablation ; Liver neoplasms/secondary ; Neoplasm recurrence ; Local ; Liver neoplasms/surgery ; FDG ; PET ; PET ; MRI ; Magnetic resonance imaging/methods ; Microwave ablation
• 刊名：BMC Medical Imaging
• 出版年：2014
• 出版时间：December 2014
• 年：2014
• 卷：14
• 期：1
• 全文大小：592 KB
• 参考文献：1. Wong, SL, Mangu, PB, Choti, MA, Crocenzi, TS, Dodd, GD, Dorfman, GS, Eng, C, Fong, Y, Giusti, AF, LU, d, Marsland, TA, Michelson, R, Poston, GJ, Schrag, D, Seidenfeld, J, Benson, AB (2010) American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer. J Clin Oncol 28: pp. 493-508 CrossRef
  2. Abdalla, EK, Vauthey, JN, Ellis, LM, Ellis, V, Pollock, R, Broglio, KR, Hess, K, Curley, SA (2004) Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239: pp. 818-825 CrossRef
  3. Van Tilborg, AAJM, Meijerink, MR, Sietses, C, Van Waesberghe, JHTM, Mackintosh, MO, Meijer, S, Van Kuijk, C, Van den Tol, P (2011) Long-term results of radiofrequency ablation for unresectable colorectal liver metastases: a potentially curative intervention. Br J Radiol 84: pp. 556-565 CrossRef
  4. Nielsen, K, van Tilborg, A, Scheffer, H, Meijerink, M, de Lange-de Klerk, E, Meijer, S, Comans, EF, Van den Tol, MP (2013) PET-CT after radiofrequency ablation of colorectal liver metastases: suggestions for timing and image interpretation. Eur J Radiol 82: pp. 2169-2175 CrossRef
  5. Nielsen, K, van Tilborg, AAJM, Meijerink, MR, Macintosh, MO, Zonderhuis, BM, de Lange, ESM, Comans, EF, Meijer, S, van den Tol, MP (2013) Incidence and treatment of local site recurrences following RFA of colorectal liver metastases. World J Surg 37: pp. 1340-1347 CrossRef
  6. Kuehl, H, Antoch, G, Stergar, H, Veit-Haibach, P, Rosenbaum-Krumme, S, Vogt, F, Frilling, A, Barkhausen, J, Bockisch, A (2008) Comparison of FDG-PET, PET/CT and MRI for follow-up of colorectal liver metastases treated with radiofrequency ablation: initial results. Eur J Radiol 67: pp. 362-371 CrossRef
  7. Frankel, TL, Gian, RK, Jarnagin, WR (2012) Preoperative imaging for hepatic resection of colorectal cancer metastasis. J Gastrointest Oncol 3: pp. 11-18
  8. Koh, DM, Collins, DJ, Wallace, T, Chau, I, Riddell, AM (2012) Combining diffusion-weighted MRI with Gd-EOB-DTPA-enhanced MRI improves the detection of colorectal liver metastases. Br J Radiol 85: pp. 980-989 CrossRef
  9. Langenhoff, BS, Oyen, WJG, Jager, GJ, Strijk, SP, Wobbes, T, Corstens, FHM (2002) Efficacy of fluorine-18-deoxyglucose positron emission tomography in detecting tumor recurrence after local ablative therapy for liver metastases: a prospective study. J Clin Oncol 20: pp. 4453-4458 CrossRef
  10. Chen, W, Zhuang, H, Cheng, G, Torigian, D, Alavi, A (2013) Comparison of FDG-PET, MRI and CT for post radiofrequency ablation evaluation of hepatic tumors. Ann Nucl Med 27: pp. 58-64 CrossRef
  11. Veit, P, Antoch, G, Stergar, H, Bockisch, A, Forsting, M, Kuehl, H (2006) Detection of residual tumor after radiofrequency ablation of liver metastasis with dual-modality PET/CT: initial results. Eur Radiol 16: pp. 80-87 CrossRef
  12. Donati, OF, Hany, TF, Reiner, CS, von Schulthess, GK, Marincek, B, Seifert, B, Weishaupt, D (2010) Value of retrospective fusion of PET and MR images in detection of hepatic metastases: comparison with 18聽F-FDG PET/CT and Gd-EOB-DTPA-enhanced MRI. J Nucl Med 51: pp. 692-699 CrossRef
  13. Beiderwellen, K, Gomez, B, Buchbender, C, Hartung, V, Poeppel, T, Nensa, F, Kuehl, H, Bockisch, A, Lauenstein, TC (2013) Depiction and characterization of liver lesions in whole body [F]-FDG PET/MRI. Eur J Radiol 82: pp. e669-e675 CrossRef
  14. Catalano, O, Rosen, B, Sahani, D, Hahn, P, Guimaraes, A, Vangel, M, Nicolai, E, Soricelli, A, Salvatore, M (2013) Clinical impact of PET/MR imaging in patients with cancer undergoing same-day PET/CT: initial experience in 134 patients--a hypothesis-generating exploratory study. Radiology.
  15. Cheng, G, Torigian, DA, Zhuang, H, Alavi, A (2013) When should we recommend use of dual time-point and delayed time-point imaging techniques in FDG PET?. Eur J Nucl Med Mol Imaging 40: pp. 779-787 CrossRef
  16. Goldberg, SN, Grassi, CJ, Cardella, JF, Charboneau, JW, Dodd, GD, Dupuy, DE, Gervais, D, Gillams, AR, Kane, RA, Lee, FT, Livraghi, T, McGahan, J, Phillips, DA, Rhim, H, Silverman, SG (2005) Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology 235: pp. 728-739 CrossRef
  17. Boellaard, R, O鈥橠oherty, MJ, Weber, WA, Mottaghy, FM, Lonsdale, MN, Stroobants, SG, Oyen, WJ, Kotzerke, J, Hoekstra, OS, Pruim, J, Marsden, PK, Tatsch, K, Hoekstra, CJ, Visser, EP, Arends, B, Verzijlbergen, FJ, Zijlstra, JM, Comans, EF, Lammertsma, AA, Paans, AM, Willemsen, AT, Beyer, T, Bockisch, A, Schaefer-Prokop, C, Delbeke, D, Baum, RP, Chiti, A, Krause, BJ (2010) FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0. Eur J Nucl Med Mol Imaging 37: pp. 181-200 CrossRef
  18. Ma, J (2008) Dixon techniques for water and fat imaging. J Magn Reson Imaging 28: pp. 543-558 CrossRef
  19. Pomfret, EA, Washburn, K, Wald, C, Nalesnik, MA, Douglas, D, Russo, M, Roberts, J, Reich, DJ, Schwartz, ME, Mieles, L, Lee, FT, Florman, S, Yao, F, Harper, A, Edwards, E, Freeman, R, Lake, J (2010) Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States. Liver Transpl 16: pp. 262-278 CrossRef
  20. Marin, D, Choudhury, KR, Gupta, RT, Ho, LM, Allen, BC, Schindera, ST, Colsher, JG, Samei, E, Nelson, RC (2013) Clinical impact of an adaptive statistical iterative reconstruction algorithm for detection of hypervascular liver tumours using a low tube voltage, high tube current MDCT technique. Eur Radiol 23: pp. 3325-3335 CrossRef
  21. White, RR, Avital, I, Sofocleous, CT, Brown, KT, Brody, LA, Covey, A, Getrajdman, GI, Jarnagin, WR, Dematteo, RP, Fong, Y, Blumgart, LH, D'Angelica, M (2007) Rates and patterns of recurrence for percutaneous radiofrequency ablation and open wedge resection for solitary colorectal liver metastasis. J Gastrointest Surg 11: pp. 256-263 CrossRef
  22. Gomez, D, Sangha, VK, Morris-Stiff, G, Malik, HZ, Guthrie, AJ, Toogood, GJ, Lodge, JP, Prasad, KR (2010) Outcomes of intensive surveillance after resection of hepatic colorectal metastases. Br J Surg 97: pp. 1552-1560 CrossRef
  23. Jones, RP, Jackson, R, Dunne, DFJ, Malik, HZ, Fenwick, SW, Poston, GJ, Ghaneh, P (2012) Systematic review and meta-analysis of follow-up after hepatectomy for colorectal liver metastases. Br J Surg 99: pp. 477-486 CrossRef
  24. Koyama, K, Okamura, T, Kawabe, J, Ozawa, N, Higashiyama, S, Ochi, H, Yamada, R (2002) The usefulness of 18聽F-FDG PET images obtained 2聽hours after intravenous injection in liver tumor. Ann Nucl Med 16: pp. 169-176 CrossRef
  25. Kuker, RA, Mesoloras, G, Gulec, SA (2007) Optimization of FDG-PET/CT imaging protocol for evaluation of patients with primary and metastatic liver disease. Int Semin Surg Oncol 4: pp. 17 CrossRef
  26. Shankar, LK, Hoffman, JM, Bacharach, S, Graham, MM, Karp, J, Lammertsma, AA, Larson, S, Mankoff, DA, Siegel, BA, Van den Abbeele, A, Yap, J, Sullivan, D (2006) Consensus recommendations for the use of 18聽F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials. J Nucl Med 47: pp. 1059-1066
  27. Boellaard, R (2009) Standards for PET image acquisition and quantitative data analysis. J Nucl Med 50: pp. 11S-20S CrossRef
  28. Haynes, RB Introduction. In: Haynes, RB, Taylor, DW, Sackett, DL eds. (1979) Compliance in Health Care. John Hopkins University Press, Baltimore, pp. 1-7
  29. Haynes, RB A critical review of the "determinants" of patient compliance with therapeutic regimens. In: Sackett, DL eds. (1976) Compliance with Therapeutic Regimens. Johns Hopkins University Press, Baltimorepp. 26
  30. Tang, TS, Patterson, SK, Roubidoux, MA, Duan, L (2009) Women鈥檚 mammography experience and its impact on screening adherence. Psychooncology 18: pp. 727-734 CrossRef
  31. Rijnsburger, AJ, Essink-Bot, ML, van Dooren, S, Borsboom, GJJM, Seynaeve, C, Bartels, CCM, Klijn, JG, Tibben, A, de Koning, HJ (2004) Impact of screening for breast cancer in high-risk women on health-related quality of life. Br J Cancer 91: pp. 69-76 CrossRef
  32. Warner, E (2004) Intensive radiologic surveillance: a focus on the psychological issues. Ann Oncol 15: pp. I43-I47 CrossRef
  33. Adams, RB, Aloia, TA, Loyer, E, Pawlik, TM, Taouli, B, Vauthey, JN (2013) Selection for hepatic resection of colorectal liver metastases: expert consensus statement. HPB (Oxford) 15: pp. 91-103 CrossRef
  34. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2342/14/27/prepub
  
• 刊物主题：Imaging / Radiology;
• 出版者：BioMed Central
• ISSN：1471-2342

文摘

Background Thermal ablation of colorectal liver metastases (CRLM) may result in local progression, which generally appear within a year of treatment. As the timely diagnosis of this progression allows potentially curative local treatment, an optimal follow-up imaging strategy is essential. PET-MRI is a one potential imaging modality, combining the advantages of PET and MRI. The aim of this study is evaluate fluorine-18 deoxyglucose positron emission tomography (FDG) PET-MRI as a modality for detection of local tumor progression during the first year following thermal ablation, as compared to the current standard, FDG PET-CT. The ability of FDG PET-MRI to detect new intrahepatic lesions, and the extent to which FDG PET-MRI alters clinical management, inter-observer variability and patient preference will also be included as secondary outcomes. Methods/Design Twenty patients undergoing treatment with radiofrequency or microwave ablation for (recurrent) CRLM will be included in this prospective trial. During the first year of follow-up, patients will be scanned at the VU University Medical Center at 3-monthly intervals using a 4-phase liver CT, FDG PET-CT and FDG PET-MRI. Patients treated with chemotherapy Discussion Improved treatment options for local site recurrences following CRLM ablation mean that accurate post-ablation staging is becoming increasingly important. The combination of the sensitivity of MRI as a detection method for small intrahepatic lesions with the ability of FDG PET to visualize enhanced metabolism at the ablation site suggests that FDG PET-MRI could potentially improve the accuracy of (early) detection of progressive disease, and thus allow swifter and more effective decision-making regarding appropriate treatment. Trial registration Trial registration number: NCT01895673